Fibroblast growth factor receptor 2 — Drug Target

All drugs that target Fibroblast growth factor receptor 2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Mucocutaneous Epithelial Cell Growth Factor [EPC]

Marketed (3)

• Kepivance · Biovitrum Ab · Mucocutaneous Epithelial Cell Growth Factor [EPC] · Immunology
  Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells.
• Lytgobi · Taiho Oncology · Oncology
• Truseltiq · Helsinn Hlthcare · Oncology